Pharmaceutical companies must in future limit the rising prices of new medicines to boost sales, according to the new chief executive of Sanofi-Aventis.

In his first interview since taking over in January, Gérard Le Fur told the Financial Times the trend of ever-higher prices for new drugs "cannot continue" and predicted that "volume will dominate over price".